糖尿病治療機器の世界市場：製品別（血糖値モニタリング機器、インスリン投与機器）の機会分析および産業予測（2020年～2030年）

世界の糖尿病治療機器の市場規模は、都市化や座りがちなライフスタイルによる糖尿病の罹患率の増加、糖尿病治療機器分野における技術の進歩、肥満人口の増加、ジャンクフードの消費量の増加、糖尿病の迅速かつ安全な診断と治療に対するニーズの高まりなどによって促進されています。

一方で、糖尿病治療機器の一部に関連する副作用が、同市場の成長を妨げる可能性があります。

当レポートでは、世界の糖尿病治療機器市場を調査しており、市場の概要、市場規模や予測、動向、成長要因および抑制要因、製品・地域別の分析など包括的な情報を提供しています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

• 市場の定義と範囲
• 主な調査結果
  • 主要投資ポケット
• ポーターのファイブフォース分析
• 主要企業のポジショニング
• 市場力学
  • 促進要因
  • 抑制要因
  • 市場機会
• 市場でのCOVID-19影響分析

第4章 糖尿病治療機器市場：製品別

• 概要
  • 市場規模と予測
• 血糖値モニタリング機器
  • 主要な市場動向、成長要因および機会
  • 市場規模と予測：地域別
  • 市場分析：国別
• インスリン投与機器
  • 主要な市場動向、成長要因および機会
  • 市場規模と予測：地域別
  • 市場分析：国別

第5章 糖尿病治療機器市場：地域別

• 概要
  • 市場規模と予測
• 北米
  • 主な動向と機会
  • 北米の市場規模と予測：製品別
  • 北米の市場規模と予測：国別
    • 米国
    • カナダ
    • メキシコ
• 欧州
  • 主な動向と機会
  • 欧州の市場規模と予測：製品別
  • 欧州の市場規模と予測：国別
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他欧州
• アジア太平洋
  • 主な動向と機会
  • アジア太平洋の市場規模と予測：製品別
  • アジア太平洋の市場規模と予測：国別
    • 日本
    • 中国
    • オーストラリア
    • インド
    • 韓国
    • その他アジア太平洋
• LAMEA
  • 主な動向と機会
  • LAMEAの市場規模と予測：製品別
  • LAMEAの市場規模と予測：国別
    • ブラジル
    • サウジアラビア
    • 南アフリカ
    • その他LAMEA

第6章 企業情勢

• イントロダクション
• 主な成功戦略
• 主要10社の製品マッピング
• 競争力のあるダッシュボード
• 競争力のあるヒートマップ
• 主な発展

第7章 企業プロファイル

• ABBOTT LABORATORIES
• ACON LABORATORIES, INC.
• BECTON, DICKINSON AND COMPANY
• JOHNSON & JOHNSON
• MEDTRONIC PLC
• NOVO NORDISK A/S
• TERUMO CORPORATION

LIST OF TABLES

• TABLE 1. GLOBAL DIABETES CARE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 2. DIABETES CARE DEVICES MARKET SIZE, FOR BLOOD GLUCOSE MONITORING DEVICES, BY REGION, 2020-2030 ($MILLION)
• TABLE 3. DIABETES CARE DEVICES MARKET FOR BLOOD GLUCOSE MONITORING DEVICES, BY COUNTRY, 2020-2030 ($MILLION)
• TABLE 4. DIABETES CARE DEVICES MARKET SIZE, FOR INSULIN DELIVERY DEVICES, BY REGION, 2020-2030 ($MILLION)
• TABLE 5. DIABETES CARE DEVICES MARKET FOR INSULIN DELIVERY DEVICES, BY COUNTRY, 2020-2030 ($MILLION)
• TABLE 6. DIABETES CARE DEVICES MARKET, BY REGION, 2020-2030 ($MILLION)
• TABLE 7. NORTH AMERICA DIABETES CARE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 8. NORTH AMERICA DIABETES CARE DEVICES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
• TABLE 9. U.S. DIABETES CARE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 10. CANADA DIABETES CARE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 11. MEXICO DIABETES CARE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 12. EUROPE DIABETES CARE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 13. EUROPE DIABETES CARE DEVICES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
• TABLE 14. GERAMNY DIABETES CARE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 15. FRANCE DIABETES CARE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 16. U.K. DIABETES CARE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 17. ITALY DIABETES CARE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 18. SPAIN DIABETES CARE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 19. REST OF EUROPE DIABETES CARE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 20. ASIA-PACIFIC DIABETES CARE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 21. ASIA-PACIFIC DIABETES CARE DEVICES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
• TABLE 22. JAPAN DIABETES CARE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 23. CHINA DIABETES CARE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 24. AUSTRALIA DIABETES CARE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 25. INDIA DIABETES CARE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 26. SOUTH KOREA DIABETES CARE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 27. REST OF EUROPE DIABETES CARE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 28. LAMEA DIABETES CARE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 29. LAMEA DIABETES CARE DEVICES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
• TABLE 30. BRAZIL DIABETES CARE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 31. SAUDI ARABIA DIABETES CARE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 32. SOUTH AFRICA DIABETES CARE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 33. REST OF LAMEA DIABETES CARE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 34.ABBOTT LABORATORIES: COMPANY SNAPSHOT
• TABLE 35.ABBOTT LABORATORIES: OPERATING SEGMENTS
• TABLE 36.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
• TABLE 37.ABBOTT LABORATORIES: NET SALES,
• TABLE 38.ABBOTT LABORATORIES: KEY STRATERGIES
• TABLE 39.ACON LABORATORIES, INC.: COMPANY SNAPSHOT
• TABLE 40.ACON LABORATORIES, INC.: OPERATING SEGMENTS
• TABLE 41.ACON LABORATORIES, INC.: PRODUCT PORTFOLIO
• TABLE 42.ACON LABORATORIES, INC.: NET SALES,
• TABLE 43.ACON LABORATORIES, INC.: KEY STRATERGIES
• TABLE 44.BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
• TABLE 45.BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
• TABLE 46.BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
• TABLE 47.BECTON, DICKINSON AND COMPANY: NET SALES,
• TABLE 48.BECTON, DICKINSON AND COMPANY: KEY STRATERGIES
• TABLE 49.JOHNSON & JOHNSON: COMPANY SNAPSHOT
• TABLE 50.JOHNSON & JOHNSON: OPERATING SEGMENTS
• TABLE 51.JOHNSON & JOHNSON: PRODUCT PORTFOLIO
• TABLE 52.JOHNSON & JOHNSON: NET SALES,
• TABLE 53.JOHNSON & JOHNSON: KEY STRATERGIES
• TABLE 54.MEDTRONIC PLC: COMPANY SNAPSHOT
• TABLE 55.MEDTRONIC PLC: OPERATING SEGMENTS
• TABLE 56.MEDTRONIC PLC: PRODUCT PORTFOLIO
• TABLE 57.MEDTRONIC PLC: NET SALES,
• TABLE 58.MEDTRONIC PLC: KEY STRATERGIES
• TABLE 59.NOVO NORDISK A/S: COMPANY SNAPSHOT
• TABLE 60.NOVO NORDISK A/S: OPERATING SEGMENTS
• TABLE 61.NOVO NORDISK A/S: PRODUCT PORTFOLIO
• TABLE 62.NOVO NORDISK A/S: NET SALES,
• TABLE 63.NOVO NORDISK A/S: KEY STRATERGIES
• TABLE 64.TERUMO CORPORATION: COMPANY SNAPSHOT
• TABLE 65.TERUMO CORPORATION: OPERATING SEGMENTS
• TABLE 66.TERUMO CORPORATION: PRODUCT PORTFOLIO
• TABLE 67.TERUMO CORPORATION: NET SALES,
• TABLE 68.TERUMO CORPORATION: KEY STRATERGIES

LIST OF FIGURES

• FIGURE 1.DIABETES CARE DEVICES MARKET SEGMENTATION
• FIGURE 2.DIABETES CARE DEVICES MARKET,2020-2030
• FIGURE 3.DIABETES CARE DEVICES MARKET,2020-2030
• FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
• FIGURE 5.PORTER FIVE-1
• FIGURE 6.PORTER FIVE-2
• FIGURE 7.PORTER FIVE-3
• FIGURE 8.PORTER FIVE-4
• FIGURE 9.PORTER FIVE-5
• FIGURE 10.TOP PLAYER POSITIONING
• FIGURE 11.DIABETES CARE DEVICES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
• FIGURE 12.DIABETES CARE DEVICES MARKET,BY PRODUCT,2020(%)
• FIGURE 13.COMPARATIVE SHARE ANALYSIS OF BLOOD GLUCOSE MONITORING DEVICES DIABETES CARE DEVICES MARKET,2020-2030(%)
• FIGURE 14.COMPARATIVE SHARE ANALYSIS OF INSULIN DELIVERY DEVICES DIABETES CARE DEVICES MARKET,2020-2030(%)
• FIGURE 15.DIABETES CARE DEVICES MARKET BY REGION,2020
• FIGURE 16.U.S. DIABETES CARE DEVICES MARKET,2020-2030($MILLION)
• FIGURE 17.CANADA DIABETES CARE DEVICES MARKET,2020-2030($MILLION)
• FIGURE 18.MEXICO DIABETES CARE DEVICES MARKET,2020-2030($MILLION)
• FIGURE 19.GERAMNY DIABETES CARE DEVICES MARKET,2020-2030($MILLION)
• FIGURE 20.FRANCE DIABETES CARE DEVICES MARKET,2020-2030($MILLION)
• FIGURE 21.U.K. DIABETES CARE DEVICES MARKET,2020-2030($MILLION)
• FIGURE 22.ITALY DIABETES CARE DEVICES MARKET,2020-2030($MILLION)
• FIGURE 23.SPAIN DIABETES CARE DEVICES MARKET,2020-2030($MILLION)
• FIGURE 24.REST OF EUROPE DIABETES CARE DEVICES MARKET,2020-2030($MILLION)
• FIGURE 25.JAPAN DIABETES CARE DEVICES MARKET,2020-2030($MILLION)
• FIGURE 26.CHINA DIABETES CARE DEVICES MARKET,2020-2030($MILLION)
• FIGURE 27.AUSTRALIA DIABETES CARE DEVICES MARKET,2020-2030($MILLION)
• FIGURE 28.INDIA DIABETES CARE DEVICES MARKET,2020-2030($MILLION)
• FIGURE 29.SOUTH KOREA DIABETES CARE DEVICES MARKET,2020-2030($MILLION)
• FIGURE 30.REST OF EUROPE DIABETES CARE DEVICES MARKET,2020-2030($MILLION)
• FIGURE 31.BRAZIL DIABETES CARE DEVICES MARKET,2020-2030($MILLION)
• FIGURE 32.SAUDI ARABIA DIABETES CARE DEVICES MARKET,2020-2030($MILLION)
• FIGURE 33.SOUTH AFRICA DIABETES CARE DEVICES MARKET,2020-2030($MILLION)
• FIGURE 34.REST OF LAMEA DIABETES CARE DEVICES MARKET,2020-2030($MILLION)
• FIGURE 35. TOP WINNING STRATEGIES, BY YEAR
• FIGURE 36. TOP WINNING STRATEGIES, BY DEVELOPMENT
• FIGURE 37. TOP WINNING STRATEGIES, BY COMPANY
• FIGURE 38.PRODUCT MAPPING OF TOP 10 PLAYERS
• FIGURE 39.COMPETITIVE DASHBOARD
• FIGURE 40.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
• FIGURE 41.ABBOTT LABORATORIES.: NET SALES ,($MILLION)
• FIGURE 42.ACON LABORATORIES, INC..: NET SALES ,($MILLION)
• FIGURE 43.BECTON, DICKINSON AND COMPANY.: NET SALES ,($MILLION)
• FIGURE 44.JOHNSON & JOHNSON.: NET SALES ,($MILLION)
• FIGURE 45.MEDTRONIC PLC.: NET SALES ,($MILLION)
• FIGURE 46.NOVO NORDISK A/S.: NET SALES ,($MILLION)
• FIGURE 47.TERUMO CORPORATION.: NET SALES ,($MILLION)

A diabetes care device is used to check the blood glucose level or the insulin level of a diabetic patient. There are mainly two types of diabetes care devices, including the blood glucose monitoring device and the insulin delivery device. Diabetes care devices include blood glucose meters, lancing devices, insulin delivery systems, and digital solutions for data management.

The major factor that contributes to the growth of the diabetes care devices market includes an increase in the incidence rate of diabetes, owing to urbanization and a sedentary lifestyle. Moreover, technological advancements in the field of diabetes devices, a rise in the obese population, an increase in consumption of junk food, and a surge in the need for rapid & safe diagnosis and treatment of diabetes boost the market growth. However, blood glucose monitoring devices do not measure the exact level of glucose in the blood but provide a range in which the blood glucose level of a patient lie. In addition, adverse effects associated with some of the diabetes care devices hinder the market growth. In addition, the rise in awareness about diabetes monitoring devices and untapped market opportunities in developing regions are expected to provide numerous opportunities for market growth.

The diabetes care devices market is segmented on the basis of product and region. Depending on the type, the market is bifurcated into blood glucose monitoring devices and insulin delivery devices. The blood glucose monitoring devices segment is categorized into testing strips, self-monitoring blood glucose meters, lancets, and continuous glucose monitoring devices. The insulin delivery devices segment is classified into insulin syringes, insulin pens, insulin pumps, and insulin jet injectors. Region-wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, Italy, the UK, Spain, and Rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA)

The list of key players profiled in this report includes Abbott Laboratories, ACON Laboratories, Inc., Ascension Diabetes Care Holdings AG (formerly diabetes case business of Bayer AG), Becton, Dickinson and Company, Nipro corporation., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Medline Industries, Novo Nordisk A/S, and Terumo Corporation.

Key players in the value chain include Arkray, Inc., Echo Therapeutics, Inc., Glysens Incorporated, Insulet Corporation, Sanofi, and Ypsomed AG.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the diabetes care devices market analysis from 2020 to 2030 to identify the prevailing diabetes care devices market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the diabetes care devices market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global diabetes care devices market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By BY PRODUCT

• Blood Glucose Monitoring Devices
• Insulin Delivery Devices

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Geramny
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • Rest of Europe
  • South Korea
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA
• Key Market Players
  • ABBOTT LABORATORIES
  • ACON LABORATORIES, INC.
  • BECTON, DICKINSON AND COMPANY
  • JOHNSON & JOHNSON
  • MEDTRONIC PLC
  • NOVO NORDISK A/S
  • TERUMO CORPORATION

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

• 1.1.Report description
• 1.2.Key market segments
• 1.3.Key benefits to the stakeholders
• 1.4.Research Methodology
  • 1.4.1.Secondary research
  • 1.4.2.Primary research
  • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

• 2.1.Key findings of the study
• 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

• 3.1.Market definition and scope
• 3.2.Key findings
  • 3.2.1.Top investment pockets
• 3.3.Porter's five forces analysis
• 3.4.Top player positioning
• 3.5.Market dynamics
  • 3.5.1.Drivers
  • 3.5.2.Restraints
  • 3.5.3.Opportunities
• 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: DIABETES CARE DEVICES MARKET, BY PRODUCT

• 4.1 Overview
  • 4.1.1 Market size and forecast
• 4.2 Blood Glucose Monitoring Devices
  • 4.2.1 Key market trends, growth factors and opportunities
  • 4.2.2 Market size and forecast, by region
  • 4.2.3 Market analysis by country
• 4.3 Insulin Delivery Devices
  • 4.3.1 Key market trends, growth factors and opportunities
  • 4.3.2 Market size and forecast, by region
  • 4.3.3 Market analysis by country

CHAPTER 5: DIABETES CARE DEVICES MARKET, BY REGION

• 5.1 Overview
  • 5.1.1 Market size and forecast
• 5.2 North America
  • 5.2.1 Key trends and opportunities
  • 5.2.2 North America Market size and forecast, by Product
  • 5.2.3 North America Market size and forecast, by country
    • 5.2.3.1 U.S.
    • 5.2.3.1.1 Market size and forecast, by Product
    • 5.2.3.2 Canada
    • 5.2.3.2.1 Market size and forecast, by Product
    • 5.2.3.3 Mexico
    • 5.2.3.3.1 Market size and forecast, by Product
• 5.3 Europe
  • 5.3.1 Key trends and opportunities
  • 5.3.2 Europe Market size and forecast, by Product
  • 5.3.3 Europe Market size and forecast, by country
    • 5.3.3.1 Geramny
    • 5.3.3.1.1 Market size and forecast, by Product
    • 5.3.3.2 France
    • 5.3.3.2.1 Market size and forecast, by Product
    • 5.3.3.3 U.K.
    • 5.3.3.3.1 Market size and forecast, by Product
    • 5.3.3.4 Italy
    • 5.3.3.4.1 Market size and forecast, by Product
    • 5.3.3.5 Spain
    • 5.3.3.5.1 Market size and forecast, by Product
    • 5.3.3.6 Rest of Europe
    • 5.3.3.6.1 Market size and forecast, by Product
• 5.4 Asia-Pacific
  • 5.4.1 Key trends and opportunities
  • 5.4.2 Asia-Pacific Market size and forecast, by Product
  • 5.4.3 Asia-Pacific Market size and forecast, by country
    • 5.4.3.1 Japan
    • 5.4.3.1.1 Market size and forecast, by Product
    • 5.4.3.2 China
    • 5.4.3.2.1 Market size and forecast, by Product
    • 5.4.3.3 Australia
    • 5.4.3.3.1 Market size and forecast, by Product
    • 5.4.3.4 India
    • 5.4.3.4.1 Market size and forecast, by Product
    • 5.4.3.5 South Korea
    • 5.4.3.5.1 Market size and forecast, by Product
    • 5.4.3.6 Rest of Europe
    • 5.4.3.6.1 Market size and forecast, by Product
• 5.5 LAMEA
  • 5.5.1 Key trends and opportunities
  • 5.5.2 LAMEA Market size and forecast, by Product
  • 5.5.3 LAMEA Market size and forecast, by country
    • 5.5.3.1 Brazil
    • 5.5.3.1.1 Market size and forecast, by Product
    • 5.5.3.2 Saudi Arabia
    • 5.5.3.2.1 Market size and forecast, by Product
    • 5.5.3.3 South Africa
    • 5.5.3.3.1 Market size and forecast, by Product
    • 5.5.3.4 Rest of LAMEA
    • 5.5.3.4.1 Market size and forecast, by Product

CHAPTER 6: COMPANY LANDSCAPE

• 6.1. Introduction
• 6.2. Top winning strategies
• 6.3. Product Mapping of Top 10 Player
• 6.4. Competitive Dashboard
• 6.5. Competitive Heatmap
• 6.6. Key developments

CHAPTER 7: COMPANY PROFILES

• 7.1 ABBOTT LABORATORIES
  • 7.1.1 Company overview
  • 7.1.2 Company snapshot
  • 7.1.3 Operating business segments
  • 7.1.4 Product portfolio
  • 7.1.5 Business performance
  • 7.1.6 Key strategic moves and developments
• 7.2 ACON LABORATORIES, INC.
  • 7.2.1 Company overview
  • 7.2.2 Company snapshot
  • 7.2.3 Operating business segments
  • 7.2.4 Product portfolio
  • 7.2.5 Business performance
  • 7.2.6 Key strategic moves and developments
• 7.3 BECTON, DICKINSON AND COMPANY
  • 7.3.1 Company overview
  • 7.3.2 Company snapshot
  • 7.3.3 Operating business segments
  • 7.3.4 Product portfolio
  • 7.3.5 Business performance
  • 7.3.6 Key strategic moves and developments
• 7.4 JOHNSON & JOHNSON
  • 7.4.1 Company overview
  • 7.4.2 Company snapshot
  • 7.4.3 Operating business segments
  • 7.4.4 Product portfolio
  • 7.4.5 Business performance
  • 7.4.6 Key strategic moves and developments
• 7.5 MEDTRONIC PLC
  • 7.5.1 Company overview
  • 7.5.2 Company snapshot
  • 7.5.3 Operating business segments
  • 7.5.4 Product portfolio
  • 7.5.5 Business performance
  • 7.5.6 Key strategic moves and developments
• 7.6 NOVO NORDISK A/S
  • 7.6.1 Company overview
  • 7.6.2 Company snapshot
  • 7.6.3 Operating business segments
  • 7.6.4 Product portfolio
  • 7.6.5 Business performance
  • 7.6.6 Key strategic moves and developments
• 7.7 TERUMO CORPORATION
  • 7.7.1 Company overview
  • 7.7.2 Company snapshot
  • 7.7.3 Operating business segments
  • 7.7.4 Product portfolio
  • 7.7.5 Business performance
  • 7.7.6 Key strategic moves and developments